Business Truist Securities lowers Corcept Therapeutics inventory value goal on FDA considerations Last updated: December 31, 2025 6:26 pm Editor Published: December 31, 2025 Share Truist Securities lowers Corcept Therapeutics inventory value goal on FDA considerations Tim Scott pushes accelerated Fed chair affirmation after Trump choose Arrow Electronics says that US commerce curbs on its Chinese language associates are being reversed Russia condemns U.S. strike on alleged drug vessel close to Venezuela Trump warns of extra strikes on Iran’s Kharg Island, pressures allies to safe oil chokepoint New Disney CEO lays off 1000 staff in new memo Sign Up For Daily NewsletterBe keep up! Get the latest breaking news delivered straight to your inbox.[mc4wp_form]By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time. Share This Article Facebook Email Copy Link Print Previous Article CLARITY Act Set to Advance as Senate Picks January 15 for Crypto Invoice Markup Next Article Will OSI (OSIS) Beat Estimates Once more in Its Subsequent Earnings Report? Leave a Comment Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Follow USFind US on Socials FacebookLikeXFollowYoutubeSubscribeTelegramFollow Popular News Success Story: Charles Tyler’s Studying Journey with 101 Blockchains Key Advantages, Use Circumstances, And Developments The Innovation Hub Playbook: Constructing a Digital Ecosystem for the Recent Meals Chain
